心血管

订阅

MedSci主页 / 所有栏目 / 心血管

PACES/HRS先心病成人心律失常认识和管理专家共识

2014-05-12 cath 医学论坛网

先心病心律失常专家共识
关注

在美国心律学会年会(HRS 2014)召开之际，《心律学》(Heart Rhythm)杂志于5月8日在线发表了《PACES/HRS先天性心脏病成人心律失常的认识和管理专家共识》。指南下载：PACES/HRS先心病成人心律失常认识和管理专家共识 原始出处：Paul Khairy, George F Van Hare, Seshadri Balaji, Charles I Berul, Frank C

在美国心律学会年会(HRS 2014)召开之际，《心律学》(Heart Rhythm)杂志于5月8日在线发表了《PACES/HRS先天性心脏病成人心律失常的认识和管理专家共识》。


该共识涉及心律失常的流行病学、心律失常的诊断和评估、药物治疗、导管消融、Brady心律失常（缓慢型心律失常）和心脏起搏器、心脏性猝死和植入式心律转复除颤器、心脏再同步治疗及手术等。


下载共识：PACES/HRS先心病成人心律失常认识和管理专家共识


原始出处：

Paul Khairy, George F Van Hare, Seshadri Balaji, Charles I Berul, Frank Cecchin, Mitchell I Cohen, Curt J Daniels, Barbara J Deal，Joseph A Dearani, Natasja de Groot, Anne M Dubin, Louise Harris, Jan Janousek, Ronald K Kanter, Peter P Karpawich, James C Perry, Stephen P Seslar, Maully J Shah, Michael J Silka, John K Triedman, Edward P Walsh, Carole A. Warnes.PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease.Heart Rhythm May 08, 2014

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1844432, encodeId=3307184443203, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Sat Jul 19 18:31:00 CST 2014, time=2014-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655696, encodeId=177016556966d, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1829, encryptionId=2a011829d7, topicName=ACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=635024767990, createdName=shanyongle, createdTime=Tue Aug 12 08:31:00 CST 2014, time=2014-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311444, encodeId=15ba1311444f0, content=<a href='/topic/show?id=a12628e0852' target=_blank style='color:#2F92EE;'>#先心病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28708, encryptionId=a12628e0852, topicName=先心病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25c8396, createdName=ssnine, createdTime=Wed May 14 00:31:00 CST 2014, time=2014-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1464098, encodeId=42761464098dd, content=<a href='/topic/show?id=da7d9119bc' target=_blank style='color:#2F92EE;'>#HRS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9119, encryptionId=da7d9119bc, topicName=HRS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=259a6588710, createdName=ysjykql, createdTime=Wed May 14 00:31:00 CST 2014, time=2014-05-14, status=1, ipAttribution=)]
    2014-07-19 snowpeakxu

    #专家共识#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1844432, encodeId=3307184443203, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Sat Jul 19 18:31:00 CST 2014, time=2014-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655696, encodeId=177016556966d, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1829, encryptionId=2a011829d7, topicName=ACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=635024767990, createdName=shanyongle, createdTime=Tue Aug 12 08:31:00 CST 2014, time=2014-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311444, encodeId=15ba1311444f0, content=<a href='/topic/show?id=a12628e0852' target=_blank style='color:#2F92EE;'>#先心病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28708, encryptionId=a12628e0852, topicName=先心病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25c8396, createdName=ssnine, createdTime=Wed May 14 00:31:00 CST 2014, time=2014-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1464098, encodeId=42761464098dd, content=<a href='/topic/show?id=da7d9119bc' target=_blank style='color:#2F92EE;'>#HRS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9119, encryptionId=da7d9119bc, topicName=HRS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=259a6588710, createdName=ysjykql, createdTime=Wed May 14 00:31:00 CST 2014, time=2014-05-14, status=1, ipAttribution=)]
    2014-08-12 shanyongle

    #ACE#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1844432, encodeId=3307184443203, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Sat Jul 19 18:31:00 CST 2014, time=2014-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655696, encodeId=177016556966d, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1829, encryptionId=2a011829d7, topicName=ACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=635024767990, createdName=shanyongle, createdTime=Tue Aug 12 08:31:00 CST 2014, time=2014-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311444, encodeId=15ba1311444f0, content=<a href='/topic/show?id=a12628e0852' target=_blank style='color:#2F92EE;'>#先心病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28708, encryptionId=a12628e0852, topicName=先心病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25c8396, createdName=ssnine, createdTime=Wed May 14 00:31:00 CST 2014, time=2014-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1464098, encodeId=42761464098dd, content=<a href='/topic/show?id=da7d9119bc' target=_blank style='color:#2F92EE;'>#HRS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9119, encryptionId=da7d9119bc, topicName=HRS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=259a6588710, createdName=ysjykql, createdTime=Wed May 14 00:31:00 CST 2014, time=2014-05-14, status=1, ipAttribution=)]
    2014-05-14 ssnine

    #先心病#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1844432, encodeId=3307184443203, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Sat Jul 19 18:31:00 CST 2014, time=2014-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655696, encodeId=177016556966d, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1829, encryptionId=2a011829d7, topicName=ACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=635024767990, createdName=shanyongle, createdTime=Tue Aug 12 08:31:00 CST 2014, time=2014-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311444, encodeId=15ba1311444f0, content=<a href='/topic/show?id=a12628e0852' target=_blank style='color:#2F92EE;'>#先心病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28708, encryptionId=a12628e0852, topicName=先心病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25c8396, createdName=ssnine, createdTime=Wed May 14 00:31:00 CST 2014, time=2014-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1464098, encodeId=42761464098dd, content=<a href='/topic/show?id=da7d9119bc' target=_blank style='color:#2F92EE;'>#HRS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9119, encryptionId=da7d9119bc, topicName=HRS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=259a6588710, createdName=ysjykql, createdTime=Wed May 14 00:31:00 CST 2014, time=2014-05-14, status=1, ipAttribution=)]
    2014-05-14 ysjykql

    #HRS#

    0

相关资讯

Lancet：复旦大学发表新生儿先天性心脏病筛查新研究

国际顶尖学术期刊《柳叶刀》（Lancet）（2013年度影响因子为39.06分）于2014年4月23日在线刊登了复旦大学附属儿科医院黄国英教授领衔的课题组关于新生儿先天性心脏病（简称“先心病”）筛查的研究成果“经皮氧饱和度测定结合临床指标筛查新生儿先心病的前瞻性研究（Pulse oximetry with clinical assessment to screen for congenital h

Circulation：多项指标与先心病心脏猝死相关

　　9月18日《循环》杂志（Circulation）在线发表一项关于先心病成年患者心脏猝死的研究，结果提示，先心病（CHD）成年患者发生心脏猝死（SCD）的相关临床指标范围较广，其中包括系统性右室功能。此外，即使轻度心脏受损的患者也有发生SCD的可能性。 　　多中心病例对照研究，对象为已确诊或推测因心律失常猝死的患者。根据诊断、手术类型、年龄和性别给每1例患者匹配2例病例对照。3个数据库中共有2

太原将为八成儿童免费筛查先心病

　　14日，记者从山西太原“儿童先天性心脏病免费筛查项目”启动会上获悉，太原市卫生局将在3年内对全市80%以上0至6岁的儿童进行免费筛查。 　　据公开资料显示，先天性心脏病(简称“先心病”)是儿童先天性疾病中最严重的一种，其发病率在中国新生儿出生缺陷中居首。太原市先心病发病率占出生缺陷发生率第4位，死亡率居5岁以下儿童死亡率第3位，先心病已成为5岁以下儿童死亡的主要因素之一。 　　为此，太原市

朱鲜阳:现代先心病管理凸显“攻防一体”

       先心病介入治疗已臻成熟， 新型器材不断问世， 并向可吸收、方便操作、减少并发症等方向进展。但应关注， 先心病产前筛查、诊断和干预才是现阶段的主攻目标。        “六一”国际儿童节前夕，卫生部发布《中国0～6岁儿童营养发展报告（2012）》显示，我国儿童的超重和肥胖问